Lilly reports second-quarter 2026 financial results, raises full-year guidance, and highlights continued growth and pipeline progress - Eli Lilly and Company
- Lilly reports second-quarter 2026 financial results, raises full-year guidance, and highlights continued growth and pipeline progress Eli Lilly and Company
- Here’s How Much Traders See Eli Lilly Stock Moving After Earnings Investopedia
- Eli Lilly Q2 2026 earnings beat, raises full-year revenue forecast qz.com
- Lilly Boosts Sales Guidance on Strong Demand for Obesity Drugs Bloomberg.com
- Lilly’s revenue soars 48%, driven by demand of its GLP-1s marketwatch.com
Related Markets
All MarketsMarket data may be delayed. Not financial advice.
💡 AI analysis provides alternative perspectives on current events